Golar LNG Ltd (NASDAQ: GLNG) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.03 versus a loss $-0.31 for the same period a year ago — a decline of -110%. For […]
Cogent Communications Holdings I (NASDAQ: CCOI) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.91 versus $4.23 for the same period a year ago — a decline of -122%. For […]
Cedar Fair LP (NYSE: FUN) has reported a loss for its fourth fiscal quarter (ending December 31) of $-2.76 versus a loss $-0.20 for the same period a year ago — an increase of 1280%. […]
For its fourth fiscal quarter (ending December 31), Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) has reported a 5% increase in E.P.S. from $0.75 a year ago to $0.79 in the current quarter. E.P.S. were $3.29 for […]
The Toronto-Dominion Bank (NYSE: TD) has reported earnings for its first fiscal quarter (ending January 31) of $1.55 versus $1.55 for the same period a year ago — flat performance. E.P.S. were $4.73 for the […]
For its fourth fiscal quarter (ending December 31), Standard Motor Products Inc. (NYSE: SMP) has reported a -112% decline in E.P.S. from $0.33 a year ago to $-0.04 in the current quarter. E.P.S. were $2.46 […]
PTC Therapeutics Inc (NASDAQ: PTCT) has reported E.P.S. of $-0.85 for its fourth fiscal quarter (ending December 31) versus $-2.06 for the same period a year ago — a decline of -59%. For the latest […]
For its third fiscal quarter (ending January 31), NetApp Inc (NASDAQ: NTAP) has reported a -3% decline in E.P.S. from $1.52 a year ago to $1.47 in the current quarter. E.P.S. were $5.54 for the […]
For its fourth fiscal quarter (ending December 31), Iovance Biotherapeutics Inc (NASDAQ: IOVA) has reported a -42% decline in E.P.S. from $-0.45 a year ago to $-0.26 in the current quarter. E.P.S. were $-1.28 for […]
For its fourth fiscal quarter (ending December 31), HCI Group Inc (NYSE: HCI) has reported a -94% decline in E.P.S. from $4.31 a year ago to $0.24 in the current quarter. E.P.S. were $10.59 for […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research